D-17
Today is  2026. 08. 24.
D-17
Today is  2026. 08. 24.

Detailed Program

Program Detailed Program
Program At a Glance Detailed Program Invited Speakers

  • Day 1 (Thu, Sep 10)
    Room A
    10:00-11:20 KOR

    Heart Failure Masterclass: The Day 1 Essentials [심부전 진단과 치료 처음부터 시작하기]

    Seongwoo Han (Hallym Univ., Korea)
    Jin Oh Choi (Sungkyunkwan Univ., Korea)

    심부전 진단과 치료를 기초부터 다시 공부해 본다.
    완전히 이해하고 있다고 생각하지만 의외로 놓치고 있는 경우가 종종 있다. 이 세션을 통해서 심부전 입문자와 전문가 모두 기초를 다시 공고히 다질 수 있도록 하고자 한다.
    10:00-10:15 HF Classification: From Ejection Fraction to Phenotypes [심부전 분류 제대로 이해하기] Jin Joo Park (Seoul National Univ., Korea)
    10:15-10:30 Biomarker Interpretation: Pitfalls to Clinical Practice [심부전 바이오마커 해석의 함정과 실제 임상적용] Hyung Yoon Kim (Incheon Sejong Hospital, Korea)
    10:30-10:45 Guideline-Directed Medical Treatment for HFrEF [박출률 감소 심부전 약물치료 이것만은 알자] Kyeong-Hyeon Chun (Yonsei Univ., Korea)
    10:45-11:00 Guideline-Directed Medical Treatment for HFpEF [박출률 보존 심부전 약물치료 이것만은 알자] Jung-Woo Son (Yonsei Wonju Univ., Korea)
    11:00-11:20 Discussion Eui-Soon Kim (The Catholic Univ., Korea)
    Jiwon Kim (Sungkyunkwan Univ., Korea)
    Minjung Park (Seoul National Univ., Korea)
    Heekyung Seo (Yonsei Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room A
    12:10-13:10 KOR/ENG

    Luncheon Session 1 Luncheon Session 1 logo

    Myung-A Kim (Jeju National Univ., Korea)
    Jin Oh Choi (Sungkyunkwan Univ., Korea)

    12:10-12:40 Real-World Experience in Diagnosing ATTR-CM in Korea Darae Kim (Sungkyunkwan Univ., Korea)
    12:40-13:10 State of the Art Diagnostics and Treatment of ATTR Cardiac Amyloidosis in 2026 Omar Siddiqi (Boston Univ., USA)
  • Day 1 (Thu, Sep 10)
    Room A
    13:10-14:30 KOR

    [Joint Session with KTCVS]

    Minimizing Risk in Heart Failure Patients: Modern Surgical and Transcatheter Solutions

    Byung Chul Chang (Cha Univ., Korea)
    Mi-Seung Shin (Gachon Univ., Korea)

    고위험 심부전 환자에서 수술적 및 경피적 중재술의 위험도를 평가하고 최적의 치료 전략을 선택하는 능력을 함양한다.
    고위험 심부전 환자에서 수술적 교정과 경피적 중재술의 선택은 심장외과와 심부전 전문의 간의 긴밀한 협력을 필요로 한다. 본 세션은 frailty 평가, 판막 재치환, 최소침습 수술 등 실제 임상에서 마주치는 고위험 상황의 최적 전략을 함께 논의하고자 한다.
    13:10-13:25 Beyond Numerical Scores: Integrating Frailty into Surgical vs. Transcatheter Decision-Making Sung Ji Park (Sungkyunkwan Univ., Korea)
    13:25-13:40 Transcatheter Valve-in-Valve Procedure for Deteriorated Bioprostheses Cheol Woong Yu (Korea Univ., Korea)
    13:40-13:55 Optimizing SAVR: Rapid Deployment and Sutureless Valves in the TAVR Era Jae-Sung Choi (Seoul National Univ., Korea)
    13:55-14:10 Tailoring Surgical Options for High-Risk HF Patients: The Role of Minimally Invasive Technique Min Ho Ju (Pusan National Univ., Thoracic and Cardiovascular Surgery, Korea)
    14:10-14:30 Discussion Ho Hyun Ko (Hallym Univ., Thoracic and Cardiovascular Surgery, Korea)
    Yun Seok Kim (Keimyung Univ., Thoracic and Cardiovascular Surgery, Korea)
    Sook Jin Lee (Hallym Univ., Korea)
    Seong-Hoon Lim (Dankook Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room A
    14:50-16:10 KOR

    Cardio-Obstetric Challenges: Managing HF and Cardiomyopathy in Pregnancy

    Myung-A Kim (Jeju National Univ., Korea)
    Soo Young Oh (Sungkyunkwan Univ., Obstetrics and Gynecology, Korea)

    임신 중 심부전 및 심근병증의 위험 인자를 평가하고 다학제적 접근법을 통한 관리 전략을 이해한다.
    심부전이나 심근병증을 동반한 여성에게 임신과 출산은 생명을 위협하는 고위험 상황이 될 수 있으며, 주산기 심근병증의 재발 위험과 보조생식술의 심혈관 영향은 아직 충분히 규명되지 않은 영역이다. 본 세션은 산부인과와의 다학제적 협력을 바탕으로 임신 관련 심부전의 위험 층화, 실제 관리 전략 및 장기 예후를 다루고자 한다.
    14:50-15:05 Pregnancy and Heart Failure: Risk Stratification and Multidisciplinary Care Kina Jeon (The Catholic Univ., Korea)
    15:05-15:20 Assisted Reproduction: Hormones, Heart Failure, and Thrombosis Seung-Yup Ku (Seoul National Univ. Obstetrics and Gynecology, Korea)
    15:20-15:35 Practical Management of Peripartum Cardiomyopathy Sunki Lee (Korea Univ., Korea)
    15:35-15:50 Strategies for Subsequent Pregnancy and Long-Term Outcomes of Peripartum Cardiomyopathy Minjung Park (Seoul National Univ., Korea)
    15:50-16:10 Discussion Mijeong Kim (The Catholic Univ., Korea)
    Sang Min Park (Eulji Univ., Korea)
    Jihee Son (Chung-Ang Univ., Korea)
    Jungwon Lee (Yonsei Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room A
    16:10-17:40 KOR

    [Joint Session with KCSWG]

    HF and Cardiogenic Shock: From Decompensation to Advanced Support

    Hyun-Jai Cho (Seoul National Univ., Korea)
    Jeong Hoon Yang (Sungkyunkwan Univ., Korea)

    심인성 쇼크에서 기계적 순환 보조 장치의 종류와 적용 시점을 이해하고 다학제적 팀 접근법을 통한 결과 최적화 전략을 습득한다.
    심인성 쇼크에서 MCS 장치의 선택과 적용 시점, bridge-to-bridge 전략, weaning 시점의 판단은 아직 표준화되지 않은 부분이 많다. 본 세션은 임펠라 국내 초기 경험을 포함한 최신 MCS 실전 적용 사례와 다학제 팀 운영 전략을 공유하고자 한다.
    16:10-16:28 Critical Decision Making: Choosing the Right MCS in Cardiogenic Shock Min-Seok Kim (Ulsan Univ., Korea)
    16:28-16:46 Early Clinical Experience of Impella in Korea: Challenges and Success Jeong Hoon Yang (Sungkyunkwan Univ., Korea)
    16:46-17:04 Bridge-to-Bridge Strategy: Transition from Temporary MCS to Durable LVAD Yang Hyun Cho (Sungkyunkwan Univ., Thoracic Surgery, Korea)
    17:04-17:22 Optimizing Outcomes: Multidisciplinary Team Approach in MCS Management Soo Yong Lee (Pusan National Univ., Korea)
    17:22-17:40 Discussion Jeehoon Kang (Seoul National Univ., Korea)
    Jihoon Kim (Hallym Univ., Thoracic and Cardiovascular Surgery, Korea)
    Shin Heayoung (Sungkyunkwan Univ., Korea)
    Jae Seung Jung (Korea Univ., Thoracic and Cardiovascular Surgery, Korea)
  • Day 1 (Thu, Sep 10)
    Room B
    10:00-11:20 ENG

    HF Therapy in Transition: From Guideline to Precision Medicine

    Seok Min Kang (Yonsei Univ., Korea)
    Dong Heon Yang (Kyungpook National Univ., Korea)

    To review the evolving landscape of heart failure therapy, from evidence-based guideline implementation to precision medicine approaches integrating genomics and multi-omics.
    Heart failure management is entering a new era where traditional guideline-based care is complemented by precision medicine. As genomic, phenotypic, and multi-omics data reshape our understanding of disease heterogeneity, this session explores how global and Korean guidelines are evolving to move beyond a “one-size-fits-all” approach.
    10:00-10:15 How Guidelines Shape HF Care? Unique Insights from Japan Takeshi Kitai (National Cerebral and Cardiovascular Center, Japan)
    10:15-10:30 What’s New in 2026? A Deep Dive into the ESC HF Guidelines Wilfried Mullens (Univ. Hasselt, Ziekenhuis Oost Limburg, Genk, Belgium)
    10:30-10:45 Where is the KSHF Guideline Heading? Integrating Korean Evidence for the Future Sang Eun Lee (Ulsan Univ., Korea)
    10:45-11:00 Revisiting the Effects of Novel HF Therapies Through Genomic and Multi-Omics Analyses Yasuhiko Sakata (National Cerebral and Cardiovascular Center, Japan)
    11:00-11:20 Discussion Kyung-Jin Kim (Ewha Womans Univ., Korea)
    Sung-Hee Shin (Inha Univ., Korea)
    Chan Joo Lee (Yonsei Univ., Korea)
    Seokjae Hwang (Gumdan Top Hospital, Korea)
  • Day 1 (Thu, Sep 10)
    Room B
    12:10-13:10 ENG

    Integrating Finerenone Across the CKM Continuum

    Luncheon Session 2 Luncheon Session 2 logo

    Seong-Mi Park (Korea Univ., Korea)
    Javed Butler (Baylor Scott & White, USA)

    12:10-12:40 The Unique Value of Kerendia®: From Mechanism to Kidney & HF Prevention Stephen Greene (Duke Clinical Research Institute, USA)
    12:40-13:10 Kerendia® Across the CKM Spectrum: From Evidence to Real-World Implementation Jin Joo Park (Seoul National Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room B
    13:10-14:30 ENG

    Current Landscape and Future Pathways of Transcatheter HF Management

    Jae-Joong Kim (Ulsan Univ., Korea)
    Koichiro Kinugawa (Univ. of Toyama, Japan)

    To understand current transcatheter treatment strategies for heart failure and explore emerging device-based interventions for structural and functional cardiac disease.
    Transcatheter therapies are rapidly expanding treatment options for heart failure patients with complex structural and valvular diseases. This session highlights contemporary evidence, optimal patient selection, and procedural concepts for novel device therapies—such as interatrial shunting and transcatheter tricuspid interventions.
    13:10-13:30 Interatrial Shunting in HF: Contemporary Evidence and Ongoing Challenges Liviu Klein (Univ. of California San Francisco, USA)
    13:30-13:50 T-TEER in Functional TR Management: Patient Selection and Outcomes Takeshi Kitai (National Cerebral and Cardiovascular Center, Japan)
    13:50-14:10 SPACER Pivot in Functional TR management: Concept to Clinical Practice Geu Ru Hong (Yonsei Univ., Korea)
    14:10-14:30 Discussion Jang Won Son (Yeungnam Univ., Korea)
    Stephen Greene (Duke Clinical Research Institute, USA)
    Yuhui Zhang (Fuwai Hospital, China)
  • Day 1 (Thu, Sep 10)
    Room B
    14:50-16:10 ENG

    [Joint Session with HFSA]

    Emerging Evidence and Changing Treatment Paradigms in Cardiomyopathy

    Byung Su Yoo (Yonsei Wonju Univ., Korea)
    Kenneth Margulies (Univ. of Pennsylvania, USA)

    To provide an updated understanding of contemporary treatment strategies and emerging evidence in cardiomyopathies, including ATTR amyloidosis and hypertrophic cardiomyopathy.
    In collaboration with the HFSA, this session reviews the rapidly evolving landscape of cardiomyopathy care driven by disease-specific and precision-based therapies. Experts will dissect contemporary evidence, real-world practices, and unresolved questions regarding targeted treatments for ATTR-CM and non-obstructive HCM using novel cardiac myosin inhibitors.
    14:50-15:10 ATTR-CM in the United States: Evidence to Practice Omar Siddiqi (Boston Univ., USA)
    15:10-15:30 Management of Obstructive HCM: Contemporary Treatment and Long-Term Outcomes Sung-Hee Shin (Inha Univ., Korea)
    15:30-15:50 Management of Non-obstructive HCM: Who Benefits from Cardiac Myosin Inhibitor? Kenneth Margulies (Univ. of Pennsylvania, USA)
    15:50-16:10 Discussion Chi Young Shim (Yonsei Univ., Korea)
    Jung Hyun Choi (Pusan National Univ., Korea)
    Matthew Martinez (Mayo Clinic, USA)
  • Day 1 (Thu, Sep 10)
    Room B
    16:10-17:40 ENG

    [Joint Session with CHFA]

    Global Lessons of Asian Heart Failure

    Myeong-Chan Cho (Chungbuk National Univ., Korea)
    Jian Zhang (Fuwai Hospital, China)

    To explore the unique clinical characteristics and management challenges of heart failure in Asian populations.
    Heart failure in Asia demonstrates distinctive phenotypes, such as lean HFpEF, unique hypertensive heart disease profiles, and specific CKM syndrome patterns. Jointly organized with the CHFA, this session highlights crucial regional perspectives, therapeutic dosing challenges, and shared experiences in mechanical circulatory support across Asian countries.
    16:10-16:28 Lean HFpEF, Hypertensive Heart Disease, and Small Ventricle in Asia Jung Hyun Choi (Pusan National Univ., Korea)
    16:28-16:46 Quadruple Therapy in Asian Patients: Efficacy, Tolerability, and Dosing Issues Yuhui Zhang (Fuwai Hospital, China)
    16:46-17:04 CKM Syndrome and Heart Failure: An Asian Epidemic Jung-Woo Son (Yonsei Wonju Univ., Korea)
    17:04-17:22 Mechanical Circulatory Support in Asian Patients with Heart Failure Xiaowei Zhang (Lanzhou Univ., China)
    17:22-17:40 Discussion Minkwan Kim (Yonsei Univ., Korea)
    Bo Eun Park (Kyungpook National Univ., Korea)
    Sukmin Seo (The Catholic Univ., Korea)
    Kangun Choi (Yeungnam Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room C
    10:00-11:20 KOR

    Everything about the Atrium in Heart Failure

    Daegyun Park (Hallym Univ., Korea)
    Sung Kee Ryu (Ewha Womans Univ., Korea)

    심부전에서 심방의 구조적·기능적 변화와 임상적 의미를 이해한다.
    심부전 진료에서 심방은 증상 발생과 예후를 결정하는 중요한 요소이다. 이 세션에서는 심방 리모델링, 심방-심실 상호작용, 침습적 혈역학 평가를 통해 심부전 환자의 병태생리를 보다 입체적으로 이해하고자 한다.
    10:00-10:15 Atrial Myopathy: The Missing Link in HFpEF Development Dong-Hyuk Cho (Korea Univ., Korea)
    10:15-10:30 Atrial Functional Changes According to Cardiac Rhythm Mi-Hyang Jung (The Catholic Univ., Korea)
    10:30-10:45 Atrio-Ventricular Coupling and Hemodynamic Consequences Kyu-Yong Ko (Yonsei Univ., Korea)
    10:45-11:00 Invasive Hemodynamics and LA Pressure Jihoon Kim (Sungkyunkwan Univ., Korea)
    11:00-11:20 Discussion Dae Young Kim (Inha Univ., Korea)
    Minjeong Kim (Ewha Womans Univ., Korea)
    Seung Hyeok Bang (Sungkyunkwan Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room C
    12:10-13:10 KOR

    Luncheon Session 3

    Jin Yong Hwang (Gyeongsang National Univ., Korea)
    In Jai Kim (CHA Univ., Korea)

    12:10-13:10 Why Shingles and RSV Prevention Matters for Patients with Heart Failure 심부전환자에게 대상포진 및 RSV 예방이 중요한 이유 Kyung-Hee Kim (Incheon Sejong Hospital, Korea)
  • Day 1 (Thu, Sep 10)
    Room C
    13:10-14:30 KOR

    AI and Digital Health in 2026 [디지털헬스연구회 Digital Health Council]

    Eung Ju Kim (Korea Univ., Korea)
    Seonghoon Choi (Hallym Univ., Korea)

    인공지능과 디지털 헬스 기술이 심부전 진료와 심혈관 영상 분야에 어떻게 적용되고 있는지 이해한다.
    의료인을 위한 AI의 기본 개념부터 심부전 진료, 심혈관 영상, 심초음파 분야의 실제 활용 사례를 살펴보고 향후 발전 방향을 조망하고자 한다.
    13:10-13:25 Understanding AI and Digital Health for Healthcare Professionals [의료인을 위한 AI, digital health의 이해] Sang-Ho Jo (Hallym Univ., Korea)
    13:25-13:40 Various Applications of ECG AI in Heart Failure [심전도 AI의 heart failure관점에서다양한 활용] Youngjin Cho (Seoul National Univ., Korea)
    13:40-13:55 Application of AI in Cardiovascular Imaging [심장혈관 영상에서 AI의적용] Dong Hyun Yang (Ulsan Univ., Radiology, Korea)
    13:55-14:10 AI-enhanced echocardiography: current and future [AI 기반 심초음파의 현재와 미래] Jiesuck Park (Seoul National Univ., Korea)
    14:10-14:30 Discussion Wonse Kim (Seoul National Univ., Artificial Intelligence, Korea)
    Sung Kee Ryu (Ewha Womans Univ., Korea)
    Minjae Yoon (Seoul National Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room C
    14:50-16:10 KOR

    Smart Management for Heart Transplant [중증심부전 연구회 Advanced Heart Failure Research Working Group]

    Seok Min Kang (Yonsei Univ., Korea)
    Jin Oh Choi (Sungkyunkwan Univ., Korea)

    진행성 심부전 환자의 최신 치료 전략과 중증심부전 관리의 핵심 이슈를 이해한다.
    최신 치료 전략과 실제 임상 경험을 공유하고, 중증심부전 환자의 예후 개선을 위한 실질적인 접근 방법을 정리한다.
    14:50-15:05 How to select best donor, My practical tip Sang Eun Lee (Ulsan Univ., Korea)
    15:05-15:20 Smart transplant allocation, Can AI help? Hyun-Jai Cho (Seoul National Univ., Korea)
    15:20-15:35 How to adjust immunosuppressants, My practical tip Darae Kim (Sungkyunkwan Univ., Korea)
    15:35-15:50 Smart immunosuppressive treatment Jaewon Oh (Yonsei Univ., Korea)
    15:50-16:10 Discussion Min-Seok Kim (Ulsan Univ., Korea)
    In-Cheol Kim (Keimyung Univ., Korea)
    Soo Yong Lee (Pusan National Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room C
    16:10-17:40 KOR

    [Ethics Session]

    Clinical and Research Ethics in Heart Failure [심부전 윤리사례집 개발: 임상과 연구에서의 실제 사례]

    Jin-Ok Jeong (Chungnam National Univ., Korea)
    Kyung-Kuk Hwang (Chungbuk National Univ., Korea)

    심부전 진료 및 연구 과정에서 발생하는 주요 윤리적 쟁점을 이해한다.
    본 세션에서는 실제 사례를 바탕으로 임상윤리와 연구윤리의 주요 쟁점을 검토하고, 환자와 연구대상자 보호를 위한 원칙을 재확인한다.
    16:10-16:28 Research Ethics (연구 윤리) Sang Hoon Na (Seoul National Univ., Korea)
    16:28-16:46 Ethical Dilemmas in Arrhythmia Procedures and Device Implantation for Very Elderly and Irreversible Brain Damage Patients [초고령, 비가역적인 뇌손상 환자의부정맥 시술 및기구치료 삽입에 대한윤리적 갈등] Dae Hwan Bae (Bucheon Sejong Hospital, Korea)
    16:46-17:04 Patient Choice and the Physician's Role - Ethical Reflections on Heart Transplant Refusal [환자의 선택과 의료진의 역할 - 심장이식을 거부한 환자의 윤리적 고찰] Mijoo Kim (Chungnam National Univ., Korea)
    17:04-17:22 Ethical Issues in Academic Presentations: When Using AI or Others' Data [학술발표 시 만나는 윤리적 순간들: AI나 타인의 자료를 이용할 때] Sang Min Park (Eulji Univ., Korea)
    17:22-17:40 Discussion Jang Young Kim (Yonsei Wonju Univ., Korea)
    Seon-Ah Jin (Chungnam National Univ., Korea)
    Uram Jin (Ajou Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room D
    13:10-14:15 KOR

    Debate 1: Fulminant Myocarditis: Steroids or Not?—Case-Based Debate Across Histotype

    Eun Seok Jeon (DaeHang Hospital, Korea)

    13:10-13:25 Fulminant Myocarditis: Challenging Treatment Decisions Across Cases Shin Heayoung (Sungkyunkwan Univ., Korea)
    13:25-13:40 Early Corticosteroids in Fulminant Myocarditis: Why Time Matters Jeong Hoon Yang (Sungkyunkwan Univ., Korea)
    13:40-13:55 Fulminant Does Not Equal Immune-Mediated: Why We Should Be Cautious Minju Han (Seoul National Univ., Korea)
    13:55-14:15 Open Dialogue and Audience Voting Hyung Yoon Kim (Incheon Sejong Hospital, Korea)
    Dong Ryeol Ryu (Kangwon National Univ., Korea)
    Jaewon Oh (Yonsei Univ., Korea)
    Dong-Hyuk Cho (Korea Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room D
    16:10-17:40 KOR

    Public Hearing on Clinical Practice Guidelines [진료지침위원회 공청회]

    Byung Su Yoo (Yonsei Wonju Univ., Korea)
    Sang Eun Lee (Ulsan Univ., Korea)

    16:10-16:20 De-escalation vs. Maintenance of GDMT in HFimpEF [HFimpEF에서 GDMT 감량(de-escalation) vs 유지] Ah-Ram Kim (Ulsan Univ., Korea)
    16:20-16:30 Effects of GLP-1 Agonist (Semaglutide) in HFpEF/HFmrEF with Obesity [비만 동반 HFpEF/HFmrEF에서 GLP-1 작용제(세마글루타이드)의 효과] Minjung Park (Seoul National Univ., Korea)
    16:30-16:40 Effects of SGLT2 Inhibitors in HFpEF/HFmrEF [HFpEF/HFmrEF에서 SGLT2 억제제의 효과] Jino Park (Inje Univ., Korea)
    16:40-16:50 Effects of ARNI (Sacubitril/Valsartan) in HFpEF/HFmrEF [HFpEF/HFmrEF에서 ARNI(사쿠비트릴/발사르탄)의 효과] Jae Yeong Cho (Chonnam National Univ., Korea)
    16:50-17:00 First-line Therapeutic Value of RNAi Therapy (Vutrisiran) in ATTR-CM [ATTR-CM에서 RNAi 치료(Vutrisiran)의 1차치료 가치] Darae Kim (Sungkyunkwan Univ., Korea)
    17:00-17:10 Effects of Early Initiation of SGLT2 Inhibitors in Hospitalized Patients with Acute Heart Failure (AHF) [급성 심부전(AHF) 입원 환자에서 SGLT2 억제제의 조기시작의 효과] Kyung-Jin Kim (Ewha Womans Univ., Korea)
    17:10-17:20 Effects of Early Initiation of ARNI (Entresto) in Hospitalized Patients with Acute Heart Failure (AHF) [급성 심부전(AHF) 입원 환자에서 ARNI(엔트레스토)의조기 시작의 효과] Dahye Kim (Presbyterian Medical Center, Korea)
    17:20-17:30 Effects of Non-steroidal MRA (Finerenone) in HFpEF/HFmrEF [HFpEF/HFmrEF에서비스테로이드성 MRA(Finerenone)의효과] Chan Joo Lee (Yonsei Univ., Korea)
    17:30-17:40 Discussion & Voting Kitae Kim (Ulsan Univ., Thoracic and Cardiovascular Surgery, Korea)
    Hyun Jung Kim (Cochrane Korea, Korea)
    Ran Heo (Hanyang Univ., Korea)
  • Day 1 (Thu, Sep 10)
    AGORA
    10:00-11:20 KOR

    HF Boot Camp 1: Mechanical Support, VAD

    10:00-10:10 Basics of LVAD: Candidate Selection and Long-Term Outcomes Junho Hyun (Ulsan Univ., Korea)
    10:10-10:20 ECLS in LVAD: From CS to post-LVAD RVF Soo Yong Lee (Pusan National Univ., Korea)
    10:20-10:30 Q&A Ah-Ram Kim (Ulsan Univ., Korea)
    Yoonjee Park (Bucheon Sejong Hospital, Korea)
    Jooyeon Lee (Yonsei Univ., Korea)
    David Hong (Sungkyunkwan Univ., Korea)
    10:30-10:45 Hands-on module
    10:45-10:50 (Mini-lecture 1) Assessment of the LVAD candidate Yoonjee Park (Bucheon Sejong Hospital, Korea)
    10:50-10:55 (Mini-lecture 2) Basic Hemodynamic and Parameters Jooyeon Lee (Yonsei Univ., Korea)
    10:55-11:00 (Mini-lecture 3) Echocardiographic and Hemodynamic Assessment after LVAD David Hong (Sungkyunkwan Univ., Korea)
    11:00-11:05 (Mini-lecture 4) Managing Critically Ill Candidates for LVAD Ah-Ram Kim (Ulsan Univ., Korea)
    11:05-11:20 Discussion Shin Heayoung (Sungkyunkwan Univ., Korea)
    Yongwhan Lim (Chonnam National Univ., Korea)
    Kina Jeon (The Catholic Univ., Korea)
  • Day 1 (Thu, Sep 10)
    AGORA
    13:10-14:30 ENG

    Moderated Poster 1

    Kye Hun Kim (Chonnam National Univ., Korea)

    13:10-13:18 Artificial Intelligence in Cardio-Oncology: A Bibliometric Analysis of the Global Research Landscape, 2010–2025 Nicholas Romin (Dr. Mohammad Hoesin General Hospital, Indonesia)
    13:18-13:26 Short-Term Prognostic Value of H2FPEF Score in Patients With Heart Failure With Preserved Ejection Fraction Khanh Hung Doan (Hue Univ., Vietnam)
    13:26-13:34 Current Status of Swallowing-Related Quality of Life and Its Associated Factors in Patients with Heart Failure Kikka Kobayashi (Kitasato Univ., Japan)
    13:34-13:42 Association of Testosterone-to-Estradiol Ratio with Inflammation and Clinical Outcomes Among Postmenopausal HFpEF Miaomiao Qi (Lanzhou Univ., China)
    13:42-13:50 ROCK2 as an Early Biomarker of Immune Checkpoint Inhibitor-Associated Myocarditis Caie Li (Lanzhou Univ., China)
    13:50-13:58 Respiratory Virus Infections in Hospitalized Patients With Acute Heart Failure Syndrome: A Prospective Multicenter Observational Study Minjae Yoon (Seoul National Univ., Korea)
    13:58-14:06 Artificial Intelligence-Enabled Electrocardiography for Early Prediction of Cancer Therapy-Related Cardiac Dysfunction: A Systematic Review and Meta-Analysis Javier Hugo Farrell Adhika (Univ. of Indonesia, Indonesia)
    14:06-14:14 Favorable Changes in Multi-Chamber Mechanics and Right Ventricular-Pulmonary Arterial Coupling After Vericiguat Initiation Heekyung Seo (Yonsei Univ., Korea)
    14:14-14:22 Feasibility, Preliminary Safety, and Six-Month Outcomes of a Transitional Cardiac Rehabilitation Program Combining Inpatient Heart Failure Education with Home-Based Elastic-Band Exercise Kyung-Hee Kim (Incheon Sejong Hospital, Korea)
  • Day 1 (Thu, Sep 10)
    AGORA
    16:40-17:40 KOR

    HF Boot Camp 2: Strategic Approaches to Research Publication

    Jin Joo Park (Seoul National Univ., Korea)
    Jong-Chan Youn (The Catholic Univ., Korea)

    16:40-16:55 심부전 임상시험에서의 Win Ratio 이해: 결과 해석부터 임상시험 설계까지 (Win Ratio in Heart Failure Trials Made Simple: From Result Interpretation to Trial Design) Danbee Kang (Sungkyunkwan Univ., Center for Clinical Epidemiology, Korea)
    16:55-17:10 IJHF Editor-in-Chief가 전하는 논문 Accept 비법 Jin Joo Park (Seoul National Univ., Korea)
    17:10-17:25 AI를 활용한 연구 Figure 제작: 논문·슬라이드용 그림을 빠르고 세련되게 만드는 방법 (AI-Assisted Research Figure Design: Creating Publication- and Presentation-Ready Visuals) Dong Su Jang (Yonsei Univ., Korea)
    17:25-17:40 Discussion Sung A Bae (Yonsei Univ., Korea)
    Taeil Yang (Gachon Univ., Korea)
    Ha Young Yu (Korea Univ., Korea)
    Ji Hyun Cha (Sungkyunkwan Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room A
    08:00-08:40 KOR/ENG

    A New Era in HFpEF/HFmrEF: The Role of Finerenone in Double Prevention

    Morning Session 1 Morning Session 1 logo

    Seok Min Kang (Yonsei Univ., Korea)

    08:00-08:20 Prevention-1: Reshaping the Pre-HF Trajectory-Disease Modification with Finerenone Chan Joo Lee (Yonsei Univ., Korea)
    08:20-08:40 Prevention-2: Beyond First Events-Reducing Total HF Burden in HFpEF/HFmrEF with Finerenone Stephen Greene (Duke Clinical Research Institute, USA)
  • Day 2 (Fri, Sep 11)
    Room A
    09:00-10:20 KOR

    Heart Failure Masterclass: The Day 2 Essentials [초심자를 위한 심부전 치료의 실제]

    Eung Ju Kim (Korea Univ., Korea)
    Seonghoon Choi (Hallym Univ., Korea)

    심부전 치료의 핵심 약제를 임상에서 실질적으로 적용하는 방법을 이해하고, 동반 질환인 심방세동의 관리 전략을 습득한다.
    심부전 약제의 실제 적용 순서와 용량 조절, 그리고 심방세동 병존 시 치료 전략은 임상에서 끊임없이 제기되는 과제이다. 본 세션은 심부전 약물치료의 실전 팁과 최신 변화를 초심자와 전문가 모두의 눈높이에서 체계적으로 정리하고자 한다.
    09:00-09:15 Practical Use of Diuretics, MRA, SGLT2 inhibitors in Heart Failure [이뇨제, MRA, SGLT2 억제제 실제 사용 TIP] Ju-Hee Lee (Chungbuk National Univ., Korea)
    09:15-09:30 Practical Use of ARNI and beta-blockers in Heart Failure [ARNI와 베타차단제 실제 사용 TIP] Sun Hwa Lee (Jeonbuk National Univ., Korea)
    09:30-09:45 Modern Drug Therapy for Heart Failure: Beyond 4 Pillar Drugs [4 Pillar 약제 이외 약제의 사용실제와 효과] Ji-Hun Jang (Inha Univ., Korea)
    09:45-10:00 Treatment Approaches for AF in Patients with HF [심부전 환자의 심방세동 치료와 변화] Jaemin Shim (Korea Univ., Korea)
    10:00-10:20 Discussion Se Eun Kim (Yonsei Wonju Univ., Korea)
    Ah-Ram Kim (Ulsan Univ., Korea)
    Jin-Jin Kim (The Catholic Univ., Korea)
    Sung A Bae (Yonsei Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room A
    10:50-12:10 KOR

    [Joint Session with KSE]

    What's Hot in Echocardiography in Heart Failure Practice?

    Goo Yeong Cho (Seoul National Univ., Korea)
    Seongwoo Han (Hallym Univ., Korea)

    심부전 진료에서 심초음파의 최신 가이드라인 적용과 AI 기반 진단 기술의 임상적 활용을 이해한다.
    이완기능 진단 가이드라인 업데이트, 기능성 승모판 역류의 감별, 인공지능 기반 자동 분석 등 심초음파 분야는 빠르게 진화하고 있다. 본 세션은 대한심장초음파학회(KSE)와 함께 심부전 진료에서 심초음파의 최신 적용 방법과 임상적 의미를 논의하고자 한다.
    10:50-11:05 2025 Updated Guideline for Diagnosis of Diastolic Function and HFpEF: Hyemoon Chung (Kyung Hee Univ., Korea)
    11:05-11:20 Ventricular vs Atrial Functional MR: Diagnosis and Treatment Dae-Hee Kim (Ulsan Univ., Korea)
    11:20-11:35 AI in Echocardiography for Diagnosis of Heart Failure Yeonyee Yoon (Seoul National Univ., Korea)
    11:35-11:50 Exercise Echocardiography in Heart Failure Eui-Young Choi (Yonsei Univ., Korea)
    11:50-12:10 Discussion Dae Hwan Bae (Bucheon Sejong Hospital, Korea)
    Jin Kyung Oh (Chungnam National Univ., Korea)
    Seonhwa Lee (Yonsei Univ., Korea)
    David Hong (Sungkyunkwan Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room A
    12:10-13:10 KOR

    Evidence-Based Management in AF and Hypertension : Evidence and Practice

    Luncheon Session 4 Luncheon Session 4 logo

    Sang Hong Baek (The Catholic Univ., Korea)
    Chi Young Shim (Yonsei Univ., Korea)

    12:10-12:40 From Continuous Monitoring to Sustained Control: CART BP Pro and Olmesartan-Based Therapy Dae-Hee Kim (Ulsan Univ., Korea)
    12:40-13:10 Importance of Medication Adherence in Patients with DOAC Min Kim (Sungkyunkwan Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room A
    13:10-14:30 ENG

    Young Investigator Award

    Myeong-Chan Cho (Chungbuk National Univ., Korea)
    Seokjae Hwang (Gumdan Top Hospital, Korea)

    Judges: Bong-Joon Kim (Kosin Univ., Korea) Hyue Mee Kim (Chung-Ang Univ., Korea) Jae-Hyeong Park (Chungnam National Univ., Korea) Jang Won Son (Yeungnam Univ., Korea) Hyun Ju Yoon (Chonnam National Univ., Korea)
    13:10-13:20 Residual Tissue Congestion Identified by Bioimpedance Despite Lower NT-proBNP Predicts Long-Term Outcomes After Acute Heart Failure Jeen Hwa Lee (Hallym Univ., Korea)
    13:20-13:30 Biomarker and Echocardiographic Phenotypes of Stage B Heart Failure in Type 2 Diabetes: Distinct Outcomes and Healthcare Resource Utilisation Chanchal Chandramouli (National Heart Centre Singapore, Singapore)
    13:30-13:40 Hemocompatibility and Clinical Outcomes of HeartMate 3 Compared With Prior-Generation Left Ventricular Assist Devices: A Single-Center Retrospective Study Jun Ho Ha (Sungkyunkwan Univ., Korea)
    13:40-13:50 Characteristics and Outcomes of Heart Transplant Recipients With and Without Prior History of Malignancy: A Nationwide Population Based Cohort Study Joon-Seok Kim (The Catholic Univ., Korea)
    13:50-14:00 Heart Failure with Declide Ejection Fraction: Incidence, Predictors, and Prognosis Christian Basile (Karolinska Institutet, Sweden)
    14:00-14:10 Heart Failure Remission with Semi‑Intrinsic LV‑Only Resynchronization: an Internal and External Prospective Vietnamese Cohort Pham Phuoc Long Doan (Hue Univ., Vietnam)
    14:10-14:20 Artificial Intelligence–Enabled Electrocardiographic Prediction and Global Risk Index Stratification (AEGIS) Score for Predicting Ejection Fraction Decline After Myocardial Infarction: A Single-Center Retrospective Cohort Study Ohchul Kwon (Seoul National Univ., Korea)
    14:20-14:30 Comparative Clinical Outcomes and Heart-Rate Control According to β-Blocker Type in Patients With HFrEF Hospitalized for Acute Heart Failure Seokchul Cho (Yonsei Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room A
    14:30-15:50 ENG

    Cardiac Amyloidosis 2026: Expanding Therapeutic Frontiers and Unresolved Controversies

    Eun Seok Jeon (DaeHang Hospital, Korea)
    Mi-Seung Shin (Gachon Univ., Korea)

    To understand early diagnostic strategies and optimal treatment selection, including tafamidis, in cardiac amyloidosis.
    Once considered rare, cardiac amyloidosis is now increasingly recognized in clinical practice. With treatment timing, mono- vs. combination therapy, and redefining success beyond survival all rapidly evolving, this session aims to discuss the cutting edge of ATTR-CM management with international experts.
    14:30-14:50 The Importance of Timing: Early Tafamidis Therapy for Sustained Disease Modification Omar Siddiqi (Boston Univ., USA)
    14:50-15:10 Emerging ATTR-CM Therapies: What's New? Jong-Chan Youn (The Catholic Univ., Korea)
    15:10-15:30 Redefining Treatment Success in ATTR-CM: Beyond Survival Darae Kim (Sungkyunkwan Univ., Korea)
    15:30-15:50 Discussion Hyung Yoon Kim (Incheon Sejong Hospital, Korea)
    Inki Moon (Soonchunhyang Univ., Korea)
    Moon-Seung Soh (Ajou Univ., Korea)
    So-Young Lee (The Catholic Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room B
    09:00-10:20 ENG

    Beyond Survival: Managing Heart Failure in the Era of Modern Cancer Therapy

    Il Suk Sohn (Kyung Hee Univ., Korea)
    Woo-Baek Chung (The Catholic Univ., Korea)

    To review contemporary approaches to cardiovascular risk assessment and heart failure management in patients receiving modern cancer therapies.
    As cancer survival rates improve, therapy-induced cardiotoxicity has become a major determinant of long-term patient outcomes. This session dives into the evolving field of cardio-oncology, discussing the practical application of risk-stratification tools, recent clinical trial evidence, and proactive monitoring strategies like permissive cardiotoxicity.
    09:00-09:15 From Data to Decisions: What Cardio‑Oncology Factsheets Teach Us Seonhwa Lee (Yonsei Univ., Korea)
    09:15-09:30 HFA-ICOS Risk Score: A Practical Bridge Between Oncology and Cardiology Darae Kim (Sungkyunkwan Univ., Korea)
    09:30-09:45 Lessons from the Latest Cardio-oncology RCTs: Shaping the Future of HF Care Hyukjin Park (Chonnam National Univ., Korea)
    09:45-10:00 Permissive Cardiotoxicity and Intensive Monitoring: A New Paradigm in Cardio-oncology Novi Yanti Sari (Siloam Hospitals Lippo Village, Indonesia)
    10:00-10:20 Discussion Hee Jun Kim (Chung-Ang Univ., Oncology, Korea)
    Hyun Ju Yoon (Chonnam National Univ., Korea)
    Jung Sun Cho (The Catholic Univ., Korea)
    Jah Yeon Choi (Korea Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room B
    10:50-12:10 ENG

    [Joint Session with HFA-ESC]

    Shaping the Future of Personalized HF Care

    Byung Su Yoo (Yonsei Wonju Univ., Korea)
    Wilfried Mullens (Univ. Hasselt, Ziekenhuis Oost Limburg, Genk, Belgium)

    To explore personalized approaches to heart failure management integrating phenotype-based therapy, device optimization, and artificial intelligence.
    Partnering with the ESC-HFA, this session highlights future-oriented approaches redefining personalized heart failure care over the coming decade. The discussions will focus on leveraging artificial intelligence, advanced biomarker integration, and precision device therapies (such as CRT-D) to tailor management to individual disease trajectories.
    10:50-11:10 Towards Personalized GDMT in Heart Failure: Rethinking Phenotype-Based Therapy Gianluigi Savarese (Karolinska Institutet and South Hospital, Sweden)
    11:10-11:30 Towards Personalized Device Therapy in Heart Failure: Rethinking CRT-D Wilfried Mullens (Univ. Hasselt, Ziekenhuis Oost Limburg, Genk, Belgium)
    11:30-11:50 Towards Personalized Therapy: Integrating Human and Artificial Intelligence In-Cheol Kim (Keimyung Univ., Korea)
    11:50-12:10 Discussion Min-Seok Kim (Ulsan Univ., Korea)
    Minjae Yoon (Seoul National Univ., Korea)
    Sunki Lee (Korea Univ., Korea)
    Christian Basile (Karolinska Institutet, Sweden)
  • Day 2 (Fri, Sep 11)
    Room B
    12:10-13:10 ENG

    Advancing Chronic HF Management: From Evidence to Early Clinical Integration

    Luncheon Session 5 Luncheon Session 5 logo

    Wook-Jin Chung (Gachon Univ., Korea)

    12:10-12:55 Jardiance in Chronic HF: Early Initiation and Practical Integration Across EF Javed Butler (Baylor Scott & White, USA)
    12:55-13:10 Discussion All
  • Day 2 (Fri, Sep 11)
    Room B
    13:10-14:30 ENG

    Mechanisms of Heart Failure: From Basic Science to Clinical Insight

    Byung Hee Oh (Incheon Sejong Hospital, Korea)
    Kenneth Margulies (Univ. of Pennsylvania, USA)

    To understand the molecular, genetic, and translational mechanisms underlying heart failure and their clinical implications.
    Heart failure remains a biologically complex syndrome driven by diverse molecular pathways. This session bridges basic science and clinical practice, translating recent discoveries in genetics, epigenetics, and cardiovascular science into actionable insights that can ultimately improve bedside patient care.
    13:10-13:40 [Presidential Lecture From HFSA] Molecular Mechanisms of Heart Failure: From Bench to Bedside Kenneth Margulies (Univ. of Pennsylvania, USA)
    13:40-13:55 Genetic and Epigenetic Insights into Heart Failure Jaewon Oh (Yonsei Univ., Korea)
    13:55-14:10 Translational Advances in Heart Failure: Bridging Novel Mechanisms and Patient Care Hyun-Jai Cho (Seoul National Univ., Korea)
    14:10-14:30 Discussion So Ree Kim (Korea Univ., Korea)
    Jun-Bean Park (Seoul National Univ., Korea)
    Hyewon Lee (Pusan National Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room B
    14:30-15:50 ENG

    Beyond Human Touch: Remote Monitoring & Protocolized Care Pathways in HF Clinics

    Dong Ju Choi (The Catholic Univ., Korea)
    Liviu Klein (Univ. of California San Francisco, USA)

    To review contemporary remote monitoring strategies and protocolized care pathways for improving outcomes in heart failure clinics.
    Modern heart failure management is extending beyond traditional outpatient clinics through digitally integrated care systems. This session explores how implantable diagnostics, EMR-integrated workflows, and structured remote monitoring pathways enable earlier detection of clinical deterioration while maintaining meaningful clinical decision-making.
    14:30-15:00 Remote Monitoring That Changes Outcomes: What to Measure, When to Act Liviu Klein (Univ. of California San Francisco, USA)
    15:00-15:15 From Reactive to Proactive: The Evolving Role of Implantable Diagnostics in HF Yongsoo Baek (Inha Univ., Korea)
    15:15-15:30 EMR-Integrated Remote Monitoring Workflows in HF Clinics Sunki Lee (Korea Univ., Korea)
    15:30-15:50 Discussion Min Gyu Kong (Soonchunhyang Univ., Korea)
    Yoonjee Park (Bucheon Sejong Hospital, Korea)
    Kyeong-Hyeon Chun (Yonsei Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room B
    16:10-17:10 ENG

    Presidential Lecture

    Byung Su Yoo (Yonsei Wonju Univ., Korea)

    16:10-16:35 Heart Failure in Japan: The Role of the Japanese Heart Failure Society Koichiro Kinugawa (Univ. of Toyama, Japan)
    16:35-17:00 Heart Failure 2026: From Guidelines to Precision, Prevention and Advocacy Wilfried Mullens (Univ. Hasselt, Ziekenhuis Oost Limburg, Genk, Belgium)
    17:00-17:10 Discussion
  • Day 2 (Fri, Sep 11)
    Room B
    17:10-17:50 KOR

    Lifetime Achievement Award

    Dong Heon Yang (Kyungpook National Univ., Korea)

    17:10-17:15 Introduction of Lifetime Achievement Award Wook-Jin Chung (Gachon Univ., Korea)
    17:15-17:45 LVAD in South Korea – Past, Present and Future Sukkeun Hong (Bucheon Sejong Hospital, Korea)
    17:45-17:50 Congratulatory Remarks Byung Su Yoo (Yonsei Wonju Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room C
    09:00-10:20 KOR

    [Joint Session with KSPH]

    Pulmonary Hypertension in Practice

    Wook-Jin Chung (Gachon Univ., Korea)
    Kye Hun Kim (Chonnam National Univ., Korea)

    폐고혈압의 진단과 치료 전략을 실제 임상 관점에서 익힌다.
    폐고혈압은 심부전 환자에서 흔히 동반되지만 진단과 치료가 쉽지 않은 영역이다. 본 세션에서는 우심도자술과 영상검사의 실제 적용부터 최신 치료 근거까지 살펴보며, 실제 진료 현장에서 마주하는 다양한 상황에 대한 해결 방안을 함께 논의하고자 한다.
    09:00-09:15 When to Suspect Pre-Capillary or Combined PH in HF: Clinical Clues and My Experience Jung Hyun Choi (Pusan National Univ., Korea)
    09:15-09:30 Right Test, Right Time: Selecting Imaging Modalities and Key Diagnostic Clues Dae-Hee Kim (Ulsan Univ., Korea)
    09:30-09:45 PAH-Targeted Therapy in PH Due to Left Heart Disease: Current Evidence and Future Directions Taeil Yang (Gachon Univ., Korea)
    09:45-10:00 From Pulmonary Angiography to Balloon Pulmonary Angioplasty: Practical Insights from Clinical Experience Cheol Min Ahn (Yonsei Univ., Korea)
    10:00-10:20 Discussion Gi Beom Kim (Seoul National Univ., Korea)
    Sang Hyun Lee (Pusan National Univ., Korea)
    Kyung Eun Ha (Gachon Univ., Korea)
    Ran Heo (Hanyang Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room C
    10:50-12:10 KOR

    From HFrEF to HFimpEF: Treat, Taper, or Maintain?

    Young Sup Byun (Inje Univ., Korea)
    Sang-Ho Jo (Hallym Univ., Korea)

    HFimpEF 환자에서 최적의 약물 유지 및 감량 전략을 이해한다.
    치료 후 심기능이 회복된 HFimpEF 환자는 점차 증가하고 있지만, 치료를 언제까지 유지해야 하는지는 여전히 중요한 논쟁거리이다. 이 세션에서는 약제별 근거를 바탕으로 치료 지속, 감량, 중단에 대한 최신 지견을 정리하고 실제 임상 의사결정에 도움을 주고자 한다.
    10:50-11:05 LV Recovery in HFrEF: Predictors, Therapeutic Drivers, and Prognostic Implications Jooyeon Lee (Yonsei Univ., Korea)
    11:05-11:20 Recovered EF After Ischemic Injury: Should Post-MI Beta-Blockers Be Continued? Jino Park (Inje Univ., Korea)
    11:20-11:35 Etiology-Driven Decisions in HFimpEF: Why Treat Forever? Nuri Lee (Chonnam National Univ., Korea)
    11:35-11:50 Not All Drugs Are Equal: Class-Specific Evidence for De-Escalation in HFimpEF Junho Hyun (Ulsan Univ., Korea)
    11:50-12:10 Discussion Moojun Kim (NHIS Ilsan Hospital, Korea)
    Jin-Jin Kim (The Catholic Univ., Korea)
    Sang Gon Yoon (Pusan National Univ., Korea)
    Kyung Hee Lim (Dong-A Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room C
    12:10-13:10 KOR

    Luncheon Session 6 Luncheon Session 6 logo

    Daegyun Park (Hallym Univ., Korea)
    Hyun-Jai Cho (Seoul National Univ., Korea)

    12:10-12:40 The role of SGLT2i in CKM management Jeonggeun Moon (Gachon Univ., Korea)
    12:40-13:10 Finding the Perfect Partner for Valsartan David Hong (Sungkyunkwan Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room C
    13:10-14:30 KOR

    [Joint Session with National Institute of Health (NIH)]

    Collaborative Research, Practical Tips and Know-How

    Jae-Hwan Nam (National Institute of Health, Korea)
    Byung Su Yoo (Yonsei Wonju Univ., Korea)

    심부전 연구에 활용 가능한 국가 연구 인프라와 다학제 연구 방법론을 이해한다.
    심부전 연구는 점차 대규모 데이터와 다학제 협력을 기반으로 발전하고 있다. 본 세션에서는 NIH 연구자원, 국가 코호트, 연구 플랫폼 활용법을 소개하고 실제 연구 수행 경험을 공유하여 연구 역량 향상에 도움을 주고자 한다.
    13:10-13:22 From Clinic to Grant: A Guide to NIH Research Grants for Clinicians [From Clinic to Grant: 임상의사를 위한 NIH 연구과제 길라잡이] Sang Cheol Kim (National Institute of Health, Korea)
    13:22-13:34 NIH Cohorts for Heart Failure Research: Beyond Cardiovascular to Chronic Disease and General Population Cohorts [심부전 연구에활용할 수 있는 NIH 코호트: 심혈관 코호트를넘어, 만성질환·일반인 코호트까지] Hyun Joung Lim (National Institute of Health, Korea)
    13:34-13:46 Global Investments in Heart Failure Research: International Trends in National Cohorts and Government-Funded Programs [세계 각국은심부전 연구에 어떻게투자하는가: 국가 코호트와국책 연구 프로그램의해외 동향] Jong-Chan Youn (The Catholic Univ., Korea)
    13:46-13:58 Research Cases Utilizing NIH Resources [NIH 연구자원을 활용한 연구사례] Yoon Shin Cho (Hallym Univ., Biomedical Science, Korea)
    13:58-14:10 From Bedside to Genome: Practical Collaborative Genomic Research in Heart Failure Utilizing NIH Infrastructure [From Bedside to Genome: NIH 인프라를 활용한 심부전유전체 협력 연구의실제] Sang Eun Lee (Ulsan Univ., Korea)
    14:10-14:30 Discussion Bong Jo Kim (National Institute of Health, Korea)
    Won-Ho Kim (National Institute of Health, Korea)
    In-Cheol Kim (Keimyung Univ., Korea)
    Ju-Hee Lee (Chungbuk National Univ., Korea)
    Jae-Pil Jeon (Korea National Institute of Health, Korea)
  • Day 2 (Fri, Sep 11)
    Room C
    14:30-15:50 KOR

    Multidisciplinary Out-of-Hospital Approaches: Reframing HF Care

    Hyun Joo Kim (Yonsei Univ., Nursing, Korea)
    Sung Hea Kim (Konkuk Univ., Korea)

    병원 밖에서 이루어지는 다학제 심부전 관리의 중요성과 실제 적용 방안을 이해한다.
    심부전 치료의 성패는 입원 중 치료뿐 아니라 퇴원 이후의 지속적인 관리에 달려 있다. 본 세션에서는 지역사회 연계, 다학제 협력, 운동 및 영양 관리 등 병원 밖에서 실현 가능한 다양한 관리 모델을 소개하며 새로운 심부전 진료 패러다임을 제시하고자 한다.
    14:30-14:45 Transitional Care Models for HF Patients: A Multidisciplinary Team Approach Jah Yeon Choi (Korea Univ., Korea)
    14:45-15:00 Sustainable HF Care Through Community Networking Myung Ju Seo (Bucheon Sejong Hospital, Nursing, Korea)
    15:00-15:15 Redefining Exercise in HF: Beyond Aerobic Tradition Kyuwan Lee (Ewha Womans Univ., Kinesiology, Korea)
    15:15-15:30 From Sodium Restriction to Muscle Nutrition: A New Dietary Perspective in HF Kyoung Eun Lee (Yonsei Univ., Nursing, Korea)
    15:30-15:50 Discussion Yoon seon Kim (Ulsan Univ., Nursing, Korea)
    Seunghyun Lee (Yonsei Univ., Korea)
    Hyeonju Jeong (MyongJi Hospital, Korea)
  • Day 2 (Fri, Sep 11)
    Room D
    09:00-10:20 KOR/ENG

    ARNI Beyond Conventional Boundaries: Expanding Across the CV Continuum

    Meets the Industries 1 Meets the Industries 1 logo

    Kyu Hyung Ryu (Techo Santepheap National Hospital, Cambodia, Korea)
    Byung Su Yoo (Yonsei Wonju Univ., Korea)

    09:00-09:20 Breaking Therapeutic Inertia in HFrEF: Closing the ARNI Gap in Korean Real-World Practice Dong-Hyuk Cho (Korea Univ., Korea)
    09:20-09:40 Global Perspectives on the Role of ARNI Across the HF Spectrum Liviu Klein (Univ. of California San Francisco, USA)
    09:40-10:00 Beyond the HF, Expanding ARNI into Hypertension Care Hae Young Lee (Seoul National Univ., Korea)
    10:00-10:20 Discussion Jino Park (Inje Univ., Korea)
    Jooyeon Lee (Yonsei Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room D
    13:10-14:30 KOR

    Healthcare System Refinement for Advanced Heart Failure [중증심부전 환자진료의 제도 보완]

    Wook-Jin Chung (Gachon Univ., Korea)
    Hae Young Lee (Seoul National Univ., Korea)

    13:10-13:25 The Need for Improving the Approval Process and Continuous Management Reimbursement for LVAD [좌심실 보조장치승인 절차 및지속 관리 수가개선 필요성] Soo Yong Lee (Pusan National Univ., Korea)
    13:25-13:40 The Need to Introduce a Certification System for LVAD and Heart Transplantation [좌심실 보조장치/심장 이식인증제 도입의 필요성] Yang Hyun Cho (Sungkyunkwan Univ., Thoracic Surgery, Korea)
    13:40-14:00 Government Policy Perspectives on Reimbursement Criteria and Management Fees for Patients with Advanced Heart Failure [중증심부전 환자 급여기준/관리수가에 대한 정부정책 기조] Jung Min Yu (Ministry of Health and Welfare, Korea)
    14:00-14:30 Discussion Young Hwan Park (Health Insurance Review & Assessment Service, Korea)
    Sukmin Seo (The Catholic Univ., Korea)
    Jae Seung Jung (Korea Univ., Thoracic and Cardiovascular Surgery, Korea)
    Sukkeun Hong (Bucheon Sejong Hospital, Korea)
  • Day 2 (Fri, Sep 11)
    Room D
    14:30-15:50 KOR

    Debate 2: Transcatheter or Transplant

    Jin-Ok Jeong (Chungnam National Univ., Korea)

    14:30-14:45 TEER First: Bridge to Recovery or Bridge to Decision? Jiwon Seo (Yonsei Univ., Korea)
    14:45-15:00 LVAD/Transplant First: Don’t Miss the Window—Early Referral Saves Lives Soo Yong Lee (Pusan National Univ., Korea)
    15:00-15:30 Rebuttal Round Jiwon Seo (Yonsei Univ., Korea)
    Soo Yong Lee (Pusan National Univ., Korea)
    15:30-15:50 Open Dialogue and Audience Voting Se Eun Kim (Yonsei Wonju Univ., Korea)
    In-Cheol Kim (Keimyung Univ., Korea)
    Minjae Yoon (Seoul National Univ., Korea)
    Junho Hyun (Ulsan Univ., Korea)
  • Day 2 (Fri, Sep 11)
    AGORA
    08:00-08:50 ENG

    Meet the Expert 1

    Experts: Koichiro Kinugawa (Univ. of Toyama, Japan) Liviu Klein (Univ. of California San Francisco, USA) Matthew Martinez (Mayo Clinic, USA) Yasuhiko Sakata (National Cerebral and Cardiovascular Center, Japan)
    will be updated.
  • Day 2 (Fri, Sep 11)
    AGORA
    08:50-10:20 ENG

    HF Clinical Research Award

    Myung-A Kim (Jeju National Univ., Korea)
    Jeong Hoon Yang (Sungkyunkwan Univ., Korea)

    Judges: Kyung-Jin Kim (Ewha Womans Univ., Korea) Jong-Ho Nam (Yeungnam Univ., Korea) Jin Wi (Gachon Univ., Korea) Sook Jin Lee (Hallym Univ., Korea) Hyemoon Chung (Kyung Hee Univ., Korea)
    08:50-08:59 Cardiorenal Anemia Syndrome and Clinical Outcomes in Patients Hospitalized for Acute Heart Failure: A Post-Hoc Analysis From the TRANS-HF Trial Moojun Kim (NHIS Ilsan Hospital, Korea)
    08:59-09:08 Comparative Effectiveness of Bisoprolol Versus Third-Generation Vasodilating Beta-Blockers in Heart Failure With Reduced Ejection Fraction: A Nationwide New-User Target-Trial Emulation Hee Jeong Lee (Keimyung Univ., Korea)
    09:08-09:17 Discharge Guideline-Directed Medical Therapy Prescription Patterns in Heart Failure Patients With Chronic Kidney Disease, Stratified by Renal Function Range: An Interim Analysis of the Multicenter KSHF-QoC Registry *On Behalf of KSHF-QoC Registry Investigators Soo Yong Lee (Pusan National Univ., Korea)
    09:17-09:26 Cardiovascular-Kidney-Metabolic Syndrome and Clinical Outcomes in Moderate Aortic Stenosis: Insights From a Multi-Center Valve Registry Jiwon Seo (Yonsei Univ., Korea)
    09:26-09:35 Complexity Loss and Day-Night Disorganization in 24-Hour Holter ECG Define an Interpretable Digital Phenotype of Heart Failure Severity Kai Zheng (Sun Yat-sen Univ., China)
    09:35-09:44 Cardiometabolic Phenotyping, but Not Ejection Fraction, Identifies the Circulating Proteomic Signature of Heart Failure Jaewoo Kim (Korea Univ., Korea)
    09:44-09:53 Clinical, Genetic, and Hemodynamic Associations of Morphological Subtypes in Hypertrophic Cardiomyopathy Kina Jeon (The Catholic Univ., Korea)
    09:53-10:02 Post-Discharge Adherence to Guideline-Directed Medical Therapy and Six-Month Outcomes in Heart Failure With Reduced Ejection Fraction: Trajectory, Components, and the Central Role of Beta Blockers — An Analysis From the TRANS-HF Trial Jee Eun Choi (Yonsei Univ., Korea)
    10:02-10:11 Left Atrial Stiffness Index and Prognosis Across Heart Failure Phenotypes in Acute Heart Failure: Insights From the STRATS-AHF Registry Ju-Hee Lee (Chungbuk National Univ., Korea)
    10:11-10:20 Discordant Ventricular Recovery and Persistent Left Atrial Remodeling in Tachycardia-Induced Cardiomyopathy: A 2-Year Analysis From the Multicenter SMILE-HF Registry Inki Moon (Soonchunhyang Univ., Korea)
  • Day 2 (Fri, Sep 11)
    AGORA
    10:20-10:50

    Vaccines and Heart Failure: An Overlooked Lifesaving Strategy

    10:20-10:50 Quiz show Seong-Mi Park (Korea Univ., Korea)
    Seong Man Bae (Ulsan Univ., Infectious Diseases, Korea)
    10:20-10:50 Discussion Hyukjin Park (Chonnam National Univ., Korea)
    Jiwon Seo (Yonsei Univ., Korea)
    Kangun Choi (Yeungnam Univ., Korea)
  • Day 2 (Fri, Sep 11)
    AGORA
    13:10-14:30 ENG

    Moderated Poster 2

    Sung-Hee Shin (Inha Univ., Korea)

    13:10-13:18 Arrhythmia Incidence Following Stem Cell Therapy for Acute Myocardial Infarction: A Systematic Review and Meta-Analysis Jaykaran Charan (AIIMS Jodhpur, India)
    13:18-13:26 GDMT Intensity at Discharge on One-Year Outcomes in HFrEF: A Multicenter Registry Study Ha Young Yu (Korea Univ., Korea)
    13:26-13:34 Long Term Outcomes of Left Bundle Branch Pacing Versus Right Ventricular Pacing in Patients With Bradyarrhythmia and Preserved Ejection Fraction With High Pacing Burden Luosha Wang (Lanzhou Univ., China)
    13:34-13:42 Enhanced External Counterpulsation and Cardiac Rehabilitation Improve Heart Failure-Related Functional Capacity in Atrial Fibrillation: A Randomized Factorial Trial Yixin Xie (Lanzhou Univ., China)
    13:42-13:50 Prognostic Value of Adjusted Echocardiographic Velocity Time Integral Change in Post-MI Cardiogenic Shock: A Novel Predictor of Outcomes Kalsoom Chachar (National Institute of Cardiovascular Diseases, Pakistan)
    13:50-13:58 Right Ventricular Strain for Early Detection of Anthracycline-Induced Cardiotoxicity in Lymphoma: A Systematic Review and Single-Arm Meta-Analysis Azzahra Noersamsjah (Pelita Harapan Univ., Indonesia)
    13:58-14:06 Early Clinical Experience and Implementation Barriers of Resistance-Based Cardiac Rehabilitation in Frail Cardiovascular Patients Kina Jeon (The Catholic Univ., Korea)
    14:06-14:14 How Much Event-Free Time Do Contemporary Therapies Provide in Heart Failure With Mildly Reduced or Preserved Ejection Fraction? A Multidomain, Reconstructed Individual Patient Data Meta-Analysis Maritza Andreanne Rafa Ayusha (Univ. of Indonesia, Indonesia)
    14:14-14:22 Mutuality Discrepancy and Caregiver Contribution to Self-Care Among Older Heart Failure Patient–Caregiver Dyads Hokon Kim (Yonsei Univ., Korea)
    14:22-14:30 Impact of a Pre-Discharge Checklist on Temporal Trends in GDMT Prescription and Clinical Events in Patients With Heart Failure Ji-Hun Jang (Inha Univ., Korea)
  • Day 2 (Fri, Sep 11)
    AGORA
    14:30-15:50 KOR

    기자간담회

    will be updated.
  • Day 3 (Sat, Sep 12)
    Room A
    08:50-10:10 KOR/ENG

    Hypertrophic Cardiomyopathy in 2026: From Risk Stratification to Targeted Therapy

    Eui-Young Choi (Yonsei Univ., Korea)
    Matthew Martinez (Mayo Clinic, USA)

    To understand risk stratification and apply the latest targeted treatments, including cardiac myosin inhibitors, in hypertrophic cardiomyopathy.
    HCM presents with heterogeneous phenotypes, making personalized risk stratification and treatment essential. With cardiac myosin inhibitors reshaping the therapeutic landscape, this session featuring Mayo Clinic experts aims to address the key clinical challenges in HCM management in 2026.
    08:50-09:05 The Silent Thick Heart: Risk Stratification and Surveillance in HCM Hyun-Jung Lee (Seoul National Univ., Korea)
    09:05-09:20 Genetic Testing in HCM: From Variant Detection to Clinical Decision-Making Jiwon Seo (Yonsei Univ., Korea)
    09:20-09:35 The New Era of HCM: Myosin Inhibitors and Personalized Treatment Strategies Matthew Martinez (Mayo Clinic, USA)
    09:35-09:50 Beyond Hypertrophy: Recognizing and Managing End-Stage HCM In-Cheol Kim (Keimyung Univ., Korea)
    09:50-10:10 Discussion Seo-Yeon Gwak (Korea Univ., Korea)
    Min Sun Kim (Inje Univ., Korea)
    Jong-Ho Nam (Yeungnam Univ., Korea)
    Hee Jeong Lee (Keimyung Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room A
    10:30-11:50 KOR

    [Joint Session with KHRS]

    Managing Arrhythmia in Heart Failure: From Chaos to Order

    Seong-Mi Park (Korea Univ., Korea)
    Eue-Keun Choi (Seoul National Univ., Korea)

    심부전 환자에서 동반되는 다양한 부정맥의 최신 치료 전략과 중재적 접근법을 이해한다.
    본 세션은 심방세동, 심실성 부정맥 및 conduction abnormality에 대한 최신 치료 전략과 device/intervention 기반 접근법을 통해 심부전 환자의 예후 개선 방안을 논의하고자 한다.
    10:30-10:45 Arrhythmia Management and Clinical Outcomes: Perspective of a HF Specialist Junho Hyun (Ulsan Univ., Korea)
    10:45-11:00 Who Benefits Most? Pulsed Field Ablation for AF in HF Hyoung-Seob Park (Keimyung Univ., Korea)
    11:00-11:15 Physiologic Pacing in HF: Is Left Bundle Branch Area Pacing a Game Changer? So Ryoung Lee (Seoul National Univ., Korea)
    11:15-11:30 Refractory Ventricular Tachycardia: From Catheter Ablation to Noninvasive Substrate Therapy Min Soo Cho (Ulsan Univ., Korea)
    11:30-11:50 Discussion Dae Young Kim (Inha Univ., Korea)
    Yun Gi Kim (Korea Univ., Korea)
    Jiwon Seo (Yonsei Univ., Korea)
    David Hong (Sungkyunkwan Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room A
    12:30-13:30 KOR

    Luncheon Session 7 Luncheon Session 7 logo

    Shung Chull Chae (Kyungpook National Univ., Korea)
    Sang Hyun Ihm (The Catholic Univ., Korea)

    12:30-13:00 Beyond beta blocker: Failing heart for β blockade + α Kyeong-Hyeon Chun (Yonsei Univ., Korea)
    13:00-13:30 Beta blocker in Patients with Cardiac Arrhythmias (DiLAF Phase 3 study) Ji-Hun Jang (Inha Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room A
    13:30-14:50 KOR

    [Session for allied professionals]

    First-line Evaluation of Acute Heart Failure Patients [급성 심부전 환자의 초기평가]

    Young Ae Kang (Ulsan Univ., Nursing, Korea)
    Ju-Hee Lee (Chungbuk National Univ., Korea)

    급성 심부전 환자의 초기 평가를 위한 실질적이고 체계적인 접근법을 이해한다.
    본 세션에서는 급성 심부전 환자의 bedside assessment, 영상 및 혈역학적 평가, 유발 인자 확인 등 실제 임상에서 활용 가능한 초기 접근 전략을 논의하고자 한다.
    13:30-13:45 Bedside Hemodynamic Profiling in Acute HF: From Classification to Treatment [급성 심부전의 혈역학: Profile 분류와 이에 맞는 치료 전략 세우기] Su Yeon Lee (Dankook Univ., Korea)
    13:45-14:00 Why Did the Patient Decompensate? Identifying the Triggers of Acute HF [왜 나빠졌을까? 급성 심부전 원인 찾기의 정석] Dong Ho Shin (Yonsei Univ., Korea)
    14:00-14:15 I/O Targets in Acute HF: Myths, Realities, and Clinical Pearls [I/O 타겟을 얼마로 할까요? I/O 잘 활용하는 비법] Ji-Hun Jang (Inha Univ., Korea)
    14:15-14:30 Genetics Behind HF: When to Suspect and How to Interpret [심부전 뒤에 숨은 유전자: 언제 의심하고 어떻게 해석할까] Uram Jin (Ajou Univ., Korea)
    14:30-14:50 Discussion Min Sun Kim (Inje Univ., Korea)
    Jisu Kim (Yonsei Univ., Nursing, Korea)
    Sohyun Lee (Korea Univ., Nursing, Korea)
    Soo Yong Lee (Pusan National Univ., Korea)
    Yunho Cho (Gyeongsang National Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room A
    15:10-16:30 KOR

    Cardio-Rheumatology Challenges: Managing Inflammation

    Hae Young Lee (Seoul National Univ., Korea)
    Sang-Ho Jo (Hallym Univ., Korea)

    염증 및 면역 반응이 심혈관질환과 심부전에 미치는 영향을 이해한다.
    염증과 면역 반응은 심혈관 질환과 심부전의 발생 및 진행에 중요한 역할을 한다. 본 세션은 cardio-rheumatology 영역에서 주목받고 있는 염증성 심근질환과 자가면역 연관 심부전에 대한 최신 지견과 치료 전략을 공유하고자 한다.
    15:10-15:25 Cardiovascular Burden in Systemic Autoimmune Rheumatic Diseases: A Rheumatologist's Perspective In Ah Choi (Korea Univ., Rheumatology, Korea)
    15:25-15:40 Modern Diagnostics for Myocarditis and Inflammatory Cardiomyopathy So Ree Kim (Korea Univ., Korea)
    15:40-15:55 Cardiac Sarcoidosis: Inflammation, Arrhythmia, and Heart Failure Jae Yeong Cho (Chonnam National Univ., Korea)
    15:55-16:10 Immunosuppression in Myocarditis and Vasculitis Hyun-Sook Kim (Soonchunhyang Univ., Rheumatology, Korea)
    16:10-16:30 Discussion Mi Hyun Kim (Catholic Kwandong Univ., Korea)
    Mijoo Kim (Chungnam National Univ., Korea)
    Jeen Hwa Lee (Hallym Univ., Korea)
    Ran Heo (Hanyang Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room B
    08:00-08:50 ENG

    Optimizing Chronic Heart Failure Care Across the EF Spectrum

    Morning Session 2 Morning Session 2 logo

    Sukkeun Hong (Bucheon Sejong Hospital, Korea)

    08:00-08:25 Addressing the Complexity of Chronic HFpEF: A CKM-Based Perspective Jae Yeong Cho (Chonnam National Univ., Korea)
    08:25-08:50 Managing Chronic HFrEF: Insights from the CKM Framework Hyue Mee Kim (Chung-Ang Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room B
    08:50-10:10 ENG

    CKM Syndrome: New Insights, Emerging Therapies, and Unresolved Challenges

    Wook-Jin Chung (Gachon Univ., Korea)
    Gianluigi Savarese (Karolinska Institutet and South Hospital, Sweden)

    To provide an updated understanding of CKM syndrome and review emerging therapeutic strategies and unresolved clinical challenges across the cardiovascular–renal–metabolic continuum.
    The emerging concept of CKM syndrome reflects the deeply interconnected nature of cardiovascular, renal, and metabolic diseases. This session reviews contemporary epidemiology, congestion biology, and unresolved clinical questions—including the expanding role of obesity management and MRAs—to help clinicians navigate these overlapping disease domains.
    08:50-09:05 Heart Failure in CKM Syndrome: Insights from Epidemiology to Risk Stratification Jin Joo Park (Seoul National Univ., Korea)
    09:05-09:20 Redefining Obesity Treatment in Heart Failure Prevention: Targeting Metabolically Unhealthy Obesity Yasuhiko Sakata (National Cerebral and Cardiovascular Center, Japan)
    09:20-09:35 Congestion and Cardiorenal Interaction in Heart Failure Wilfried Mullens (Univ. Hasselt, Ziekenhuis Oost Limburg, Genk, Belgium)
    09:35-09:50 Who Should Receive MRAs in CKM Syndrome? Bridging the Gap Between Guidelines and Practice Javed Butler (Baylor Scott & White, USA)
    09:50-10:10 Discussion Seong-Mi Park (Korea Univ., Korea)
    Dae Hwan Bae (Bucheon Sejong Hospital, Korea)
    Kina Jeon (The Catholic Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room B
    10:30-11:50 ENG

    [Joint Session with JHFS]

    Decision-Making in Heart Failure: Navigating Uncertainty and Unmet Needs

    Dong Heon Yang (Kyungpook National Univ., Korea)
    Koichiro Kinugawa (Univ. of Toyama, Japan)

    To understand contemporary decision-making strategies in complex clinical situations of heart failure management.
    Despite major advances in HF therapy, many clinical situations still require individualized decision-making beyond guideline recommendations. This session will discuss practical approaches for managing uncertainty and unmet needs in HF care.
    10:30-10:45 BNP-based Heart Failure Care: A Japanese Model for Precision Medicine Koichiro Kuwahara (Shinshu Univ., Japan)
    10:45-11:00 Phenotyping-based Heart Failure Care: From Risk Stratification to Treatment Dong-Hyuk Cho (Korea Univ., Korea)
    11:00-11:15 Atrial Functional MR in Heart Failure: From Evidence to Practice Hiroshi Ueno (Univ. of Toyama, Japan)
    11:15-11:30 Functional TR in Heart Failure: From Evidence to Practice Chi Young Shim (Yonsei Univ., Korea)
    11:30-11:50 Discussion Sung Ji Park (Sungkyunkwan Univ., Korea)
    Nuri Lee (Chonnam National Univ., Korea)
    Hyemoon Chung (Kyung Hee Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room B
    12:30-13:30 ENG

    Changing the Trajectory before the Next event with ARNI

    Luncheon Session 8 Luncheon Session 8 logo

    Dong Heon Yang (Kyungpook National Univ., Korea)

    12:30-12:50 A U.S. Perspective: Acting Earlier to Prevent the Next Heart Failure Event with ARNI Liviu Klein (Univ. of California San Francisco, USA)
    12:50-13:10 A Korean Perspective: Translating Evidence into Everyday Clinical Practice with ARNI Sunki Lee (Korea Univ., Korea)
    13:10-13:30 Discussion All
  • Day 3 (Sat, Sep 12)
    Room B
    13:30-14:50 ENG

    Tailoring Modern HF Therapy: Integrating Evidence-Based Evolution into Practice

    Seok Min Kang (Yonsei Univ., Korea)
    Koichiro Kinugawa (Univ. of Toyama, Japan)

    To understand how evolving evidence can be effectively integrated into contemporary heart failure management.
    Rapid advances in HF research continue to reshape clinical practice. This session will review recent evidence and discuss practical strategies for translating clinical trial findings into real-world HF care.
    13:30-13:50 SGLT2 Inhibitors in Heart Failure: Translating Evidence into Multi-Organ Benefits Javed Butler (Baylor Scott & White, USA)
    13:50-14:10 Big Data to Bedside: Harmonizing Registry Evidence with Randomized Clinical Trials Gianluigi Savarese (Karolinska Institutet and South Hospital, Sweden)
    14:10-14:30 The Evolution of Heart Failure: Leveraging Past Insights to Shape Future Progress Byung Su Yoo (Yonsei Wonju Univ., Korea)
    14:30-14:50 Discussion Kyung-Jin Kim (Ewha Womans Univ., Korea)
    Min-Seok Kim (Ulsan Univ., Korea)
    Jaewon Oh (Yonsei Univ., Korea)
    Christian Basile (Karolinska Institutet, Sweden)
  • Day 3 (Sat, Sep 12)
    Room B
    15:10-16:30 ENG

    Hot Topics in HF: Navigating the EF Spectrum

    Seonghoon Choi (Hallym Univ., Korea)
    Jian Zhang (Fuwai Hospital, China)

    To understand recent advances in heart failure management across the ejection fraction spectrum.
    HF encompasses diverse phenotypes according to left ventricular ejection fraction. This session will review emerging evidence and evolving therapeutic strategies for HFrEF, HFpEF, and HFimpEF.
    15:10-15:30 Top 3 Clinical Research in HFrEF (2025-2026) Novi Yanti Sari (Siloam Hospitals Lippo Village, Indonesia)
    15:30-15:50 Top 3 Clinical Research in HFpEF (2025-2026) Koichiro Kuwahara (Shinshu Univ., Japan)
    15:50-16:10 Top 3 Clinical Research in HFimpEF (2025-2026) Ji-Hun Jang (Inha Univ., Korea)
    16:10-16:30 Discussion Moojun Kim (NHIS Ilsan Hospital, Korea)
    Jooyeon Lee (Yonsei Univ., Korea)
    Kyung Eun Ha (Gachon Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room B
    16:30-

    Lucky Draw and Closing Remark

    will be updated.
  • Day 3 (Sat, Sep 12)
    Room C
    08:50-10:10 KOR

    Ischemic Cardiomyopathy: Which Truly Saves the Heart?

    Choong-Won Goh (Ewha Womans Univ., Korea)
    Kyung-Kuk Hwang (Chungbuk National Univ., Korea)

    허혈성 심근병증 환자의 예후를 개선하는 핵심 치료 전략을 이해한다.
    허혈성 심근병증은 여전히 심부전의 주요 원인 중 하나이며 다양한 치료 선택지가 존재한다. 본 세션에서는 약물치료, 재관류치료, 기계적 순환보조장치 및 심장재활의 역할을 균형 있게 조명하여 실제 환자에게 가장 효과적인 치료 전략이 무엇인지 함께 고민해보고자 한다.
    08:50-09:05 GDMT Is Enough: Optimizing Ischemic CMP with Medical Therapy Yoonjee Park (Bucheon Sejong Hospital, Korea)
    09:05-09:20 Revascularization Is Essential: Changing Prognosis in Ischemic CMP Joo Myung Lee (Sungkyunkwan Univ., Korea)
    09:20-09:35 Mechanical Circulatory Support Is Necessary During High-Risk PCI in Ischemic CMP Ji Hyun Cha (Sungkyunkwan Univ., Korea)
    09:35-09:50 Cardiac Rehabilitation Should Not Be Overlooked in Ischemic CMP Min Gyu Kong (Soonchunhyang Univ., Korea)
    09:50-10:10 Discussion Jin Wi (Gachon Univ., Korea)
    Soo Youn Lee (Incheon Sejong Hospital, Korea)
    Hyun-Su Ha (Yonsei Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room C
    10:30-11:50 KOR

    Up to Date for Heart Failure Research [정밀의료및유전체연구회 Heart Failure Precision Medicine and Genomic Research Association]

    Myeong-Chan Cho (Chungbuk National Univ., Korea)
    Jin-Ok Jeong (Chungnam National Univ., Korea)

    인간 심장 오가노이드와 engineered platform 기반의 최신 중개연구 기법을 이해한다.
    심부전 연구는 patient-specific modeling과 advanced bioengineering 기술의 발전으로 새로운 전환점을 맞이하고 있다. 본 세션은 cardiac organoid와 engineered platform 기반 연구의 최신 동향과 임상 적용 가능성을 소개하고자 한다.
    10:30-10:50 Engineering the Human Heart in a Dish: Current State of Cardiac Organoids Soah Lee (Sungkyunkwan Univ., Pharmacy, Korea)
    10:50-11:10 The Janus Face of VUS: A Spectrum from Hot to Benign Jaewon Oh (Yonsei Univ., Korea)
    11:10-11:30 Genome sequencing, Short vs. Long Read Sangwoo Kim (Yonsei Univ., Korea)
    11:30-11:50 Discussion Kyung-Hee Kim (Incheon Sejong Hospital, Korea)
    Sang Eun Lee (Ulsan Univ., Korea)
    Wook-Jin Chung (Gachon Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room C
    12:30-13:30 KOR

    Luncheon Session 9 Luncheon Session 9 logo

    Ki-Chul Sung (Sungkyunkwan Univ., Korea)
    Eun Joo Cho (The Catholic Univ., Korea)

    12:30-13:00 Addressing the Complexity of Chronic HFpEF ; A CKM-Based Perspective Jaewon Oh (Yonsei Univ., Korea)
    13:00-13:30 Managing Chronic HFrEF ; Insights from the CKM Framework Sang Eun Lee (Ulsan Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room C
    13:30-14:50 KOR

    Advanced Heart Failure Therapies: Innovations in Mechanical Support and Transplantation

    Sung-Ho Jung (Ulsan Univ., Thoracic and Cardiovascular Surgery, Korea)
    Hyun-Jai Cho (Seoul National Univ., Korea)

    심부전 연구는 patient-specific modeling과 advanced bioengineering 기술의 발전으로 새로운 전환점을 맞이하고 있다. 본 세션은 cardiac organoid와 engineered platform 기반 연구의 최신 동향과 임상 적용 가능성을 소개하고자 한다.
    본 세션은 최신 device therapy, transplantation innovation 및 미래 치료 방향에 대해 논의하고자 한다.
    13:30-13:45 Next-Generation LVADs: Engineering Advances, Hemocompatibility, and the Vision for Fully Implantable Support Kyung-Hee Kim (Incheon Sejong Hospital, Korea)
    13:45-14:00 Smarter MCS with Predictive Monitoring, Adaptive Flow, and Precision Support Ah-Ram Kim (Ulsan Univ., Korea)
    14:00-14:15 Beyond the Ideal Donor: Expanding the Donor Pool through Advanced Preservation and DCD Strategies Kitae Kim (Ulsan Univ., Thoracic and Cardiovascular Surgery, Korea)
    14:15-14:30 Current Evidence, Remaining Barriers, and Future Directions of Cardiac Xenotransplantation Jong-Chan Youn (The Catholic Univ., Korea)
    14:30-14:50 Discussion In-Cheol Kim (Keimyung Univ., Korea)
    Hyunil Kim (Optipharm, Korea)
    Yu Rim Shin (Yonsei Univ., Thoracic and Cardiovascular Surgery, Korea)
    Min Ho Ju (Pusan National Univ., Thoracic and Cardiovascular Surgery, Korea)
  • Day 3 (Sat, Sep 12)
    Room C
    15:10-16:30 KOR

    Everyday Clinical Management of HF: Practical Guidance for Physicians

    Jun Kwan (Kwans Heart Clinic, Korea)
    Jin Oh Choi (Sungkyunkwan Univ., Korea)

    실제 임상에서 흔히 접하는 심부전 관리 상황에 대한 practical approach를 이해한다.
    본 세션은 실제 진료에서 자주 마주하는 상황들을 중심으로 practical하고 적용 가능한 심부전 환자의 장기 관리 전략을 공유하고자 한다.
    15:10-15:30 Practical Evaluation of Dyspnea: Is It Heart Failure? [호흡곤란, 심부전 진단의 실전 포인트] Bong-Joon Kim (Kosin Univ., Korea)
    15:30-15:50 From Hospital to Clinic: Maintaining GDMT in Stable HF [대학병원에서 재의뢰된 안정된 심부전 환자, GDMT 유지법] Hyejung Choi (Hallym Univ., Korea)
    15:50-16:10 AF with RVR in HF Patients: Practical Approach to Acute and Ongoing Management [심부전 환자의 빠른 심방세동, 초동 대처와 만성 약물치료] Hee-Sun Mun (Yonsei Univ., Korea)
    16:10-16:30 Discussion Jee Eun Kwon (Kwon Ki-ik Internal Medicine Clinic, Korea)
    Sahng Lee (Smart Internal Medicine Clinic, Korea)
    Seong Choon Choe (OK Heart Internal Medicine Clinic, Korea)
  • Day 3 (Sat, Sep 12)
    Room D
    08:50-10:10 KOR

    Digital Health in Heart Failure Care: From Early Detection to Continuous Monitoring

    Meets the Industries 2 Meets the Industries 2 logo

    Dong Ju Choi (The Catholic Univ., Korea)
    Eung Ju Kim (Korea Univ., Korea)

    08:50-09:10 Advances in ECG-Based AI for Heart Failure Screening : From Innovation to Clinical Practice Junmyung Kwon (Medical AI Inc., Korea)
    09:10-09:30 Digital Monitoring for GDMT Optimization in Heart Failure Junho Hyun (Ulsan Univ., Korea)
    09:30-09:50 Pioneering Inpatient Telemonitoring : The Differentiated Value of thynC Minjae Yoon (Seoul National Univ., Korea)
    09:50-10:10 Discussion Jong-Chan Youn (The Catholic Univ., Korea)
    Ki-Hyun Jeon (Seoul National Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room D
    10:30-11:50 KOR/ENG

    Meets the Industries 3 Meets the Industries 3 logo

    Kee Sik Kim (Daegu Medical Center, Korea)
    Shin-Jae Kim (Ulsan Univ., Korea)

    10:30-10:50 Practical Approaches and Clinical Experience in the Diagnosis of ATTR-CM Jang Won Son (Yeungnam Univ., Korea)
    10:50-11:10 Real-World Experience with Tafamidis in Clinical Practice Omar Siddiqi (Boston Univ., USA)
    11:10-11:30 Complications in Patients with ATTR: Stroke, Bleeding, Arrhythmia, and Other Clinical Challenges In-Cheol Kim (Keimyung Univ., Korea)
    11:30-11:50 Discussion Seo-Yeon Gwak (Korea Univ., Korea)
    Shin Heayoung (Sungkyunkwan Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room D
    13:30-14:50 KOR

    Debate 3: Weight Reduction in Heart Failure

    Hae Young Lee (Seoul National Univ., Korea)

    13:30-13:45 Weight reduction should be actively pursued as standard HF therapy Kangun Choi (Yeungnam Univ., Korea)
    13:45-14:00 Weight reduction is not universally beneficial; can be harmful in many HF patients Junho Hyun (Ulsan Univ., Korea)
    14:00-14:30 Rebuttal Round Kangun Choi (Yeungnam Univ., Korea)
    Junho Hyun (Ulsan Univ., Korea)
    14:30-14:50 Open Dialogue and Audience Voting Darae Kim (Sungkyunkwan Univ., Korea)
    Bum-Sung Kim (Konkuk Univ., Korea)
    Yoonjee Park (Bucheon Sejong Hospital, Korea)
    Sunki Lee (Korea Univ., Korea)
    Kyeong-Hyeon Chun (Yonsei Univ., Korea)
  • Day 3 (Sat, Sep 12)
    AGORA
    08:00-08:50 ENG

    Meet the Expert 2

    Experts: Gianluigi Savarese (Karolinska Institutet and South Hospital, Sweden) Javed Butler (Baylor Scott & White, USA) Kenneth Margulies (Univ. of Pennsylvania, USA) Wilfried Mullens (Univ. Hasselt, Ziekenhuis Oost Limburg, Genk, Belgium)
    will be updated.
  • Day 3 (Sat, Sep 12)
    AGORA
    08:50-10:10 ENG

    Moderated Poster 3

    Jin Oh Choi (Sungkyunkwan Univ., Korea)

    08:50-08:58 Underuse of Sodium-Glucose Cotransporter-2 Inhibitors and Adverse Outcomes in Asian Octogenarians With Heart Failure With Reduced Ejection Fraction Min Yi Park (Inha Univ., Korea)
    08:58-09:06 Prospective Evaluation of Early Neurodevelopmental Outcomes and Risk Factors Following Congenital Heart Surgery in Infants Monirujjaman Biswas (Institute of Health and Respiratory Diseases, India)
    09:06-09:14 Cumulative Exposure and Longitudinal Trajectories of the Cholesterol, High-Density Lipoprotein, Glucose and Body Mass Index and Risk of Incident Cardiovascular Disease: A Prospective Cohort Study Ke Wang (Lanzhou Univ., China)
    09:14-09:22 RBM25 Regulates Cardiomyocyte PAWR Secretion and Impairs Endothelial Angiogenesis Via the GRP78-Dependent Apoptotic Axis After Myocardial Infarction Ziwei Zhu (Lanzhou Univ., China)
    09:22-09:30 Artificial Intelligence for Heart Failure Detection and Phenotyping: A Systematic Review of Diagnostic Performance Across Data Modalities Nicolaus Wahjoepramono (Pelita Harapan Univ., Indonesia)
    09:30-09:38 Heart Failure Service Capacity in Low- and Middle-Income Countries: A Cross-Country Assessment of Infrastructure, Clinical Services, and Advanced Therapies Naseer Ahmed (Rehman Medical Institute, Pakistan)
    09:38-09:46 Unveiling the Burden of Frailty in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Prevalence and Associated Outcomes Martin Aurelius Kar (Univ. of Indonesia, Indonesia)
    09:46-09:54 Integrative Transcriptomic Profiling Arrhythmogenic Right Ventricle Cardiomyopathy Compared to Cardiomyopathy Dilatation and Non-Failing Hearts Vindasya Almeira (Univ. of Indonesia, Indonesia)
    09:54-10:02 Exploratory Identification of Candidate Digital Biomarkers for Heart Failure Using Smartphone-Based Remote Photoplethysmography Jooyeon Lee (Yonsei Univ., Korea)
    10:02-10:10 Natriuretic Peptides as an Outcome-Predictive Biomarker in Heart Failure: Evidence From Recent Randomized Controlled Trials Ha Eun Oh (Ulsan Univ., Korea)
  • Day 3 (Sat, Sep 12)
    AGORA
    10:30-11:50 KOR

    HF Boot Camp 3: Mastering Sarcopenia and Rehabilitation in Heart Failure

    Daegyun Park (Hallym Univ., Korea)
    Eung Ju Kim (Korea Univ., Korea)

    10:30-10:40 Reframing Heart Failure Through the Lens of Sarcopenia Chan Joo Lee (Yonsei Univ., Korea)
    10:40-10:50 How to Prescribe Exercise in Heart Failure: Real-World Rehabilitation Protocols Byeong Ju Lee (Pusan National Univ., Rehabilitation Medicine, Korea)
    10:50-11:00 How to Read CPET: A Step-by-Step Clinical Guide Seung Hak Lee (Ulsan Univ., Rehabilitation Medicine, Korea)
    11:00-11:50 Muscle-Heart Challenges and Discussion: Try it Yourself! Min Gyu Kong (Soonchunhyang Univ., Korea)
    So Ree Kim (Korea Univ., Korea)
    Se Eun Kim (Yonsei Wonju Univ., Korea)
    Taeil Yang (Gachon Univ., Korea)
    Kangun Choi (Yeungnam Univ., Korea)
  • Day 3 (Sat, Sep 12)
    AGORA
    13:30-14:40 ENG

    Heart Failure Seoul Meets Asia: Korea Training Reflections from Asia

    Kyu Hyung Ryu (Techo Santepheap National Hospital, Cambodia, Korea)
    Wook-Jin Chung (Gachon Univ., Korea)

    13:30-13:40 Heart Failure Management in Indonesia Nicolaus Wahjoepramono (Pelita Harapan Univ., Indonesia)
    13:40-13:50 Enhancing Heart Failure Care in Vietnam Pham Phuoc Long Doan (Hue Univ., Vietnam)
    13:50-14:00 Building HF Infrastructure in Mongolia Tsend-Ayush Altangerel (District Hospital, Mongolia)
    14:00-14:10 From Korea Training to Local Practice: Cambodian Reflections Kimpor CHEA (Techo Santepheap National Hospital, Cambodia)
    14:10-14:40 Discussion Anuar Zhunussov (National Scientific Medical Centre, Kazakhstan)
    Mochamad Ali Sobirin (Diponegoro Univ., Indonesia)
  • Day 3 (Sat, Sep 12)
    AGORA
    15:00-16:20 KOR

    Life Beyond HF Clinic

    Jae-Hyeong Park (Chungnam National Univ., Korea)
    Jung Hyun Choi (Pusan National Univ., Korea)

    15:00-15:20 The Thrill of Motor Sports [모터스포츠, 생각보다 가까이 있어요] 🏎️ Nuri Lee (Chonnam National Univ., Korea)
    15:20-15:40 Refresh Yourself with a Getaway [잠깐 떠나도 괜찮아, 나를 회복하는 여행] 🏖️ Minsoo Kim (Asan Heart Internal Medicine Clinic, Korea)
    15:40-16:00 A Joyful Life with Wine [비싸지 않아도 괜찮아: 쉽고 즐거운 와인 생활] 🍷 Jino Park (Inje Univ., Korea)
    16:00-16:20 Discussion Seo-Yeon Gwak (Korea Univ., Korea)
    Hyukjin Park (Chonnam National Univ., Korea)
    Kyeong-Hyeon Chun (Yonsei Univ., Korea)
    Yu Jung Jung (Keimyung Univ., Korea)
    Junho Hyun (Ulsan Univ., Korea)